融资方面，华强科技当日融资买入2401.01万元。当前融资余额1.50亿元，占流通市值的1.71%，融资余 额超过近一年90%分位水平，处于高位。 融券方面，华强科技8月25日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年90%分位水平，处于高位。 资料显示，湖北华强科技股份有限公司位于中国(湖北)自贸区宜昌片区生物产业园东临路499号，成立 日期2001年11月12日，上市日期2021年12月6日，公司主营业务涉及生产个体防护装备、集体防护装备, 以提升我国各军兵种在核生化威胁条件下的生存和作战能力;同时依托技术优势,积极开拓医药包装、医 疗器械等民品市场。主营业务收入构成为：药用丁基胶塞54.78%，集体防护装备26.37%，其他主营 9.97%，个体防护装备4.65%，其他(补充)4.22%。 8月25日，华强科技跌0.16%，成交额1.60亿元。两融数据显示，当日华强科技获融资买入额2401.01万 元，融资偿还2341.83万元，融资净买入59.18万元。截至8月25日，华强科技融资融券余额合计1.50亿 元。 分红 ...

Core Viewpoint - The company reported a revenue of 611 million yuan for the year, a year-on-year increase of 6.74%, and a net profit attributable to shareholders of 22.53 million yuan, up 184.26% year-on-year [1][2] Group 1: Collective Protective Equipment - Revenue from collective protective equipment reached 161 million yuan, growing by 68.31%, with a gross margin of 4.45%, compared to -17.85% the previous year [1][5] - The significant increase in revenue and the turnaround in gross margin are attributed to the first batch of orders for the 239 product, which generated 123.46 million yuan in sales, accounting for 188.67% of the revenue growth in this segment [5][6] - As of the end of 2024, the contract liabilities for collective protective equipment stood at 857,300 yuan, indicating a sustainable revenue outlook based on new orders [6] Group 2: Individual Protective Equipment - Revenue from individual protective equipment fell to 28.44 million yuan, a decline of 59.24%, primarily due to decreased demand [1][8] - The company has no outstanding orders for individual protective equipment as of the end of 2024, but new orders amounting to 97.27 million yuan were received in early 2025, which are expected to support revenue in the next 1-2 years [10][11] Group 3: Pharmaceutical Butyl Rubber Stoppers - The revenue for pharmaceutical butyl rubber stoppers was 334.87 million yuan, a slight increase of 0.78% year-on-year, with a gross margin of 23.07%, down 2.56 percentage points from the previous year [12][13] - The decline in gross margin is attributed to increased competition, a slower adjustment of high-margin product structures, and rising raw material costs [15][24] - The company has implemented measures to optimize production capacity and control costs, resulting in a gross margin of 27.87% for the first quarter of 2025, indicating some recovery [16][24] Group 4: Customer and Supplier Dynamics - The top five customers accounted for 32.16% of total sales, with significant changes due to increased demand for military trade products [25][28] - The top five suppliers represented 51.65% of total purchases, with new suppliers added to meet specific product needs, reflecting a stable supply chain [30]